The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Trump announced big discounts to popular weight loss drugs Wegovy and Zepbound (also available for Diabetes treatment under ...

Get the latest news and live updates as the government shutdown enters Day 37, with FAA cuts to flights and energy bill assistance cuts looming.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy ...

NBC News' Tom Llamas talks to CEO of Eli Lilly David Ricks about the company's new deal with the Trump administration to cut ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...

The White House’s weight-loss drug briefing was halted after Novo Nordisk executive Gordon Findlay fainted on camera, ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Even after Trump’s new deal, obesity drugs are still too expensive.

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.